This is a preview of subscription content, log in via an institution to check access.
Notes
see PharmacoEconomics & Outcomes News 682 p11; 801085701
Reference
Scottish Medicines Consortium. SMC advice: adalimumab (Humira); aflibercept (Zaltrap); everolimus (Afinitor); latanoprost (Monopost). Internet Document : 8 Jul 2013. Available from: URL: http://www.scottishmedicines.org.uk
Rights and permissions
About this article
Cite this article
Recent SMC advice. PharmacoEcon Outcomes News 683, 10 (2013). https://doi.org/10.1007/s40274-013-0584-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0584-2